Here to help break down this new painkiller is Dr. Sean Mackey. He’s a Professor of Anesthesiology and Medicine at Stanford ...

The FDA has approved Merilog, the first-ever rapid-acting insulin biosimilar for diabetes treatment that helps manage blood ...

Eli Lilly’s (LLY) new weight loss pill is still in clinical trials and has not yet been approved by regulators. But that hasn ...

On January 30, the U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid ...

The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...

The US FDA has approved Journavx, a new pain reliever without the risks for addiction or overdose linked to drugs like Vicodin and OxyContin.

Descovy treats and helps prevent HIV in some people, but it isn’t used as PrEP for females. Find out why and what other ...

The US Food and Drug Administration has approved vimseltinib (Romvimza, Deciphera Pharmaceuticals, LLC) to treat adult ...

The health secretary is planning to remove members of a panel that recommends vaccines if he sees conflicts of interest.

Back in 2019, Daiichi's Turalio scored its FDA approval based on a 39% overall response rate at Week 25, versus 0% for placebo, also in TGCT patients for whom surgery was not recommended.

Trulicity (dulaglutide) is a prescription drug that can cause weight loss in some people but is not approved for this use.

Feb 15 (Reuters) - The U.S. Food and Drug Administration approved British drugmaker ... The company told the agency it would not market the product in the European Union for commercial reasons.